Sunrest Lifescience has been growing earnings at an average annual rate of 33.2%, while the Pharmaceuticals industry saw earnings growing at 14.2% annually. Revenues have been growing at an average rate of 23% per year. Sunrest Lifescience's return on equity is 27%, and it has net margins of 5.8%.
Key information
33.20%
Earnings growth rate
22.25%
EPS growth rate
Pharmaceuticals Industry Growth
17.49%
Revenue growth rate
23.01%
Return on equity
26.99%
Net Margin
5.81%
Last Earnings Update
31 Mar 2026
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Sunrest Lifescience makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
NSEI:SUNREST Revenue, expenses and earnings (INR Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
708
41
76
0
31 Dec 25
614
29
68
0
30 Sep 25
520
18
61
0
30 Jun 25
427
19
55
0
31 Mar 25
334
20
50
0
31 Dec 24
329
4
47
0
30 Sep 24
324
-12
45
0
30 Jun 24
315
-2
43
0
31 Mar 24
295
2
40
0
31 Dec 23
278
8
39
0
31 Mar 23
246
20
33
0
31 Mar 22
269
8
27
0
31 Mar 21
169
2
25
0
31 Mar 20
110
0
22
0
Quality Earnings: SUNREST has a high level of non-cash earnings.
Growing Profit Margin: SUNREST's current net profit margins (5.8%) are lower than last year (6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SUNREST's earnings have grown significantly by 33.2% per year over the past 5 years.
Accelerating Growth: SUNREST's earnings growth over the past year (105.3%) exceeds its 5-year average (33.2% per year).
Earnings vs Industry: SUNREST earnings growth over the past year (105.3%) exceeded the Pharmaceuticals industry 15.9%.
Return on Equity
High ROE: SUNREST's Return on Equity (27%) is considered high.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/30 13:55
End of Day Share Price
2026/06/30 00:00
Earnings
2026/03/31
Annual Earnings
2026/03/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sunrest Lifescience Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.